Roles of AIM2 Gene and AIM2 Inflammasome in the Pathogenesis and Treatment of Psoriasis
Authors:
Open Access
- 2 September 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 13, 929162
Abstract
Psoriasis is an immune-mediated chronic inflammatory skin disease caused by a combination of environmental incentives, polygenic genetic control, and immune regulation. The inflammation-related gene absent in melanoma 2 (AIM2) was identified as a susceptibility gene for psoriasis. AIM2 inflammasome formed from the combination of AIM2, PYD-linked apoptosis-associated speck-like protein (ASC) and Caspase-1 promotes the maturation and release of inflammatory cytokines such as IL-1β and IL-18, and triggers an inflammatory response. Studies showed the genetic and epigenetic associations between AIM2 gene and psoriasis. AIM2 gene has an essential role in the occurrence and development of psoriasis, and the inhibitors of AIM2 inflammasome will be new therapeutic targets for psoriasis. In this review, we summarized the roles of the AIM2 gene and AIM2 inflammasome in pathogenesis and treatment of psoriasis, hopefully providing a better understanding and new insight into the roles of AIM2 gene and AIM2 inflammasome in psoriasis.Keywords
This publication has 73 references indexed in Scilit:
- Strong induction of AIM2 expression in human epidermis in acute and chronic inflammatory skin conditionsExperimental Dermatology, 2012
- Expression patterns of histone deacetylases in experimental stroke and potential targets for neuroprotectionClinical and Experimental Pharmacology and Physiology, 2012
- Cathelicidin LL-37: An Antimicrobial Peptide with a Role in Inflammatory Skin DiseaseAnnals of Dermatology, 2012
- Human keratinocytes express AIM2 and respond to dsDNA with IL-1β secretionExperimental Dermatology, 2011
- Cytosolic DNA Triggers Inflammasome Activation in Keratinocytes in Psoriatic LesionsScience Translational Medicine, 2011
- Narrowband ultraviolet B treatment improves vitamin D balance and alters antimicrobial peptide expression in skin lesions of psoriasis and atopic dermatitisBritish Journal of Dermatology, 2010
- Vitamin D Analogs Differentially Control Antimicrobial Peptide/“Alarmin”Expression in PsoriasisPLOS ONE, 2009
- AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASCNature, 2009
- AIM2 activates the inflammasome and cell death in response to cytoplasmic DNANature, 2009
- Combination therapy to treat moderate to severe psoriasisJournal of the American Academy of Dermatology, 2004